SSI Diagnostica Group Acquires InDevR

SSI Diagnostica Group Acquires Gulf Coast Scientific

April 28, 2025

Medical Devices

SSI Diagnostica Group (Denmark) has acquired Gulf Coast Scientific, a Florida-based in‑vitro diagnostics company specializing in Urea Breath Testing for Helicobacter pylori. The deal expands SSI Diagnostica Group's gastrointestinal diagnostic portfolio and strengthens its footprint in the US clinical diagnostics market.

SSI Diagnostica (Adelis) Acquires TECHLAB, Inc. from Pharos Capital

August 22, 2022

Medical Devices

SSI Diagnostica, a portfolio company of Adelis Equity, has acquired TECHLAB, Inc. from Pharos Capital Group. The acquisition combines SSI Diagnostica's global distribution and production capabilities with TECHLAB's U.S. R&D and manufacturing to grow the combined diagnostics business; TECHLAB will continue operating from its Virginia facilities and retain its management team and workforce.

SSI Strategy Acquires NDA Group AB

August 15, 2023

Healthcare Services

SSI Strategy has entered into a definitive agreement to acquire NDA Group AB, a regulatory affairs and drug development consultancy, to create an integrated life sciences consultancy offering end-to-end drug development and regulatory services. The combination, supported by SSI's private equity partner Amulet Capital Partners, expands SSI's regulatory capabilities and geographic footprint across the U.S. and Europe.

InductiveHealth Acquires SSDataInfo

January 15, 2026

Healthcare Services

InductiveHealth has acquired SSDataInfo (SSDI) to strengthen its disease surveillance and public health technology offerings, combining SSDI's NEDSS Base System (NBS) expertise with InductiveHealth's cloud hosting, integrations, and data-quality capabilities. The deal expands hosting, interoperability, electronic onboarding, and ongoing support options for federal, state, tribal, territorial, and local public health agencies; together the companies serve more than 40 public health departments and agencies across the United States.

ESO Acquires Interdev Technologies

March 14, 2022

Healthcare Services

ESO, a Texas-based data and software company serving emergency medical services and public safety, has acquired Toronto-based Interdev Technologies, a provider of cloud-based ePCR and records-management software. The acquisition extends ESO's footprint in Canada and brings Interdev's ePCR, credential management and analytics capabilities into ESO's health and safety software ecosystem.

Investindustrial Acquires Proveris Scientific Corporation

January 13, 2026

Medical Devices

An independently managed investment subsidiary of Investindustrial Growth III SCSp has acquired Proveris Scientific Corporation, a Hudson, Massachusetts-based maker of spray and aerosol analytical testing instrumentation, software and lab services focused on orally inhaled and nasal drug products (OINDP). Investindustrial will partner with Proveris' management (founder Dino Farina reinvested as a minority shareholder) to accelerate global expansion and build a broader pharmaceutical testing equipment group through organic growth and add-on acquisitions.